Investor Relations
Theralase Inc. is a subsidiary of Theralase Technologies Inc. (TLT – TSX.V)
Theralase Inc. Milestones
| 1995 | Canadian federal incorporation |
| 1998 | $250k equity financing (TLC-1000) |
| 2002 | $600k equity financing (FDA clinical study) |
| 2003 | $500k equity financing (RTO Theralase Technologies) |
| 2004 | ISO-13485 approval (Health Canada) |
| 2005 | FDA 510k approval (USA) |
| 2007E | CE approval (Europe) |
Share Information
| Stock Exchanges | TSX Venture Exchange OTC BB Nasdaq |
| Trading Symbols | TLT – (TSX Venture Exchange) TLTFF – (OTC BB Nasdaq) |
| Free Trading | 22,757,817 |
| Escrow | 10,328,908 |
| Total Issued & Outstanding | 33,236,725 |
SEDAR Filings
Stock Quote
- Stock quotes provided by the TSX Group.
- For a current Stock Quote, please Click Here